Ultragenyx: Q1 Earnings SnapshotMay 5, 2022 GMTNOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $152.3 million in its first quarter.On a per-share basis, the Novato, California-based company said it had a loss of $2.19.